ストックスクリーナーアプリを入手
12.83
2.89%
0.36
前日終値:
$12.47
開ける：
$12.42
24時間の取引高:
4.42M
Relative Volume:
2.14
時価総額：
$3.20B
収益：
$496.43M
当期純損益:
$71.35M
株価収益率:
45.03
EPS:
0.2849
ネットキャッシュフロー:
$151.57M
1週間 パフォーマンス:
-0.08%
1か月 パフォーマンス:
-5.87%
6か月 パフォーマンス:
-31.39%
1年 パフォーマンス:
-17.76%
1日の値動き範囲:
$12.22
$12.98
1週間の範囲:
$12.22
$13.24
52週間の値動き範囲:
$11.02
$19.98
Cellebrite Di Ltd Stock (CLBT) Company Profile
Compare CLBT vs MSFT, ORCL, PLTR, CRWD, FTNT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CLBT
Cellebrite Di Ltd
|
12.83 | 3.20B | 496.43M | 71.35M | 151.57M | 0.2849 |
MSFT
Microsoft Corp
|
379.40 | 2.82T | 318.27B | 125.22B | 72.92B | 16.79 |
ORCL
Oracle Corp
|
184.29 | 530.03B | 64.08B | 16.40B | -24.74B | 5.5698 |
PLTR
Palantir Technologies Inc
|
128.47 | 307.98B | 5.22B | 2.29B | 2.69B | 0.8876 |
CRWD
Crowdstrike Holdings Inc
|
684.86 | 174.34B | 5.09B | -24.89M | 1.43B | -0.1885 |
FTNT
Fortinet Inc
|
144.73 | 106.04B | 7.11B | 1.95B | 2.44B | 2.5883 |
Cellebrite Di Ltd Stock (CLBT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-03-28 | 繰り返されました | Needham | Buy |
| 2024-03-13 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2024-02-16 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-07-19 | 開始されました | Craig Hallum | Buy |
| 2022-08-12 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-08-12 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2022-02-24 | 開始されました | JP Morgan | Overweight |
| 2022-02-11 | 開始されました | Deutsche Bank | Buy |
| 2021-12-02 | 開始されました | BofA Securities | Buy |
| 2021-10-21 | 開始されました | Citigroup | Buy |
すべてを表示
Cellebrite Di Ltd (CLBT) 最新ニュース
Is Cellebrite DI Ltd. (CLBT) A Good Stock To Buy Now? - Insider Monkey
10 Stocks Under $20 That Will Explode - Insider Monkey
Cellebrite DI Ltd (CLBT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cellebrite DI Ltd (CLBT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cellebrite DI Ltd (CLBT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cellebrite DI Ltd (CLBT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cellebrite DI Ltd (CLBT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cellebrite DI Ltd (CLBT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cellebrite DI Ltd (CLBT) Institutional Confidence - TradingKey
Cellebrite DI Ltd (CLBT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cellebrite DI Ltd (CLBT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Will Cellebrite’s AI‑Powered Genesis Platform Redefine Cellebrite DI's (CLBT) Narrative on Evidence Analysis? - simplywall.st
Cellebrite DI Ltd Faces Market Dynamics as Stock Volatility Surges - timothysykes.com
Cellebrite: Stronger Fundamentals Support A Buy Rating (NASDAQ:CLBT) - Seeking Alpha
Cellebrite Genesis: AI-Powered Investigative Solutions - SecurityInformed.com
Cellebrite Genesis: AI investigative tool launch - SourceSecurity.com
Cellebrite Launches the New Age of Investigations with Genesis, Now Generally Available - Macau Business
[PRNewswire] Cellebrite Launches the New Age of Investigations - Yonhap News Agency
Cellebrite DI Ltd. (CLBT) Latest Stock News & Headlines - Yahoo Finance
CLBT: AI-powered tools now deliver rapid, multi-source investigative insights, transforming case workflows - TradingView
Cellebrite launches AI investigation tool Genesis By Investing.com - Investing.com
Cellebrite Di Ltd. Announces General Availability of Genesis - marketscreener.com
Cellebrite DI Ltd stock (IL0011384071): Focus on digital intelligence growth after recent earnings - AD HOC NEWS
Cellebrite Announces Upcoming Investor Events on June 10, 2026 - PR Newswire
Cellebrite receives FedRAMP High Authorization for cloud platform - Investing.com
[PRNewswire] Cellebrite Announces Upcoming Investor Events - Yonhap News Agency
3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market - The Motley Fool
TD Cowen reiterates Buy rating on Cellebrite stock at $23 target By Investing.com - Investing.com South Africa
TD Cowen reiterates Buy rating on Cellebrite stock at $23 target - Investing.com Australia
Tracking How the Cellebrite (CLBT) Investment Narrative Is Evolving Without New Analyst Targets - Yahoo Finance
CLBT News | CELLEBRITE DI LTD (NASDAQ:CLBT) - ChartMill
Cellebrite DI Ltd. Hits Day High with 11.59% Surge in Stock Price - MarketsMojo
Cellebrite DI Ltd. Hits Day High with 7.74% Surge in Stock Price - Markets Mojo
Cellebrite DI (CLBT) Is Up 20.4% After FedRAMP Win And AI Launch MomentumHas The Bull Case Changed? - simplywall.st
126,264-share resale planned for CLBT (NASDAQ: CLBT) via Morgan Stanley - Stock Titan
Why is Cellebrite DI stock rallying 6% today? By Investing.com - Investing.com South Africa
Is It Time To Reassess Cellebrite DI (CLBT) After The Recent Share Price Rebound? - simplywall.st
Why is Cellebrite stock surging 8% today? By Investing.com - Investing.com Australia
CLBT: Upcoming Virtual Meeting Announced for June 4 - GuruFocus
A Look At Cellebrite DI (NasdaqGS:CLBT) Valuation As AI And FedRAMP Cloud Momentum Build - simplywall.st
Cellebrite DI Ltd. (CLBTW) Stock Price, News, Quote & History - Yahoo Finance
Cellebrite DI Eyes AI, Cloud and FedRAMP as Digital Investigations Demand Grows - MarketBeat
TD Cowen Maintains Cellebrite(CLBT.US) With Buy Rating, Maintains Target Price $23 - Moomoo
D.A. Davidson Maintains Cellebrite(CLBT.US) With Buy Rating, Maintains Target Price $20 - Moomoo
DA Davidson initiates coverage of Cellebrite DI (CLBT) with buy recommendation - MSN
D.A. Davidson Initiates Cellebrite(CLBT.US) With Buy Rating, Announces Target Price $20 - Moomoo
Cellebrite (CLBT) CMO sells 5,673 RSU shares under 10b5-1 trading plan - Stock Titan
Cellebrite Di Ltd (CLBT) 財務データ
収益
当期純利益
現金流量
EPS
2.66%
1.24%
大文字化:
|
ボリューム (24 時間):